Filing Flows › Companies › MiniMed Group › Cash flow
MiniMed Group cash flow, quarter by quarter
Latest: Q2 2026 · from the cash-flow statements filed with the SEC
Free cash flow−$90.0M in Q2 2026
Analysis
In Q2 2026, MiniMed Group generated −$49.0M of operating cash flow and spent $41.0M on capital projects, leaving free cash flow of −$90.0M.
Operating cash flow was −$170M against net income of −$185M. The largest differences: inventory +$64.0M, deferred taxes −$55.0M, depreciation & amortization +$39.0M.
Its cash conversion cycle was 82 days (receivables 46 + inventory 95 − payables 59).
Free cash flow
Where the cash came from and went
From profit to cash
| Quarter | Receivable days | Inventory days | Payable days | Cash conversion cycle |
|---|---|---|---|---|
| Q2 2026 | 22 | 90 | 54 | 59 |
| Q1 2026 | 46 | 95 | 59 | 82 |
Every quarter
| Quarter | Operating cash flow | Capital spending | Shares issued | Cash drawn (+) / kept (−) | Free cash flow |
|---|---|---|---|---|---|
| Q2 2026 | −$49.0M | −$41.0M | — | $91.0M | −$90.0M |
| Q1 2026 | −$170M | −$56.0M | $229M | −$287M | −$226M |
| Q2 2025 | −$141M | −$53.0M | — | $2.0M | −$194M |
| Q1 2025 | $83.0M | −$57.0M | — | −$1.0M | $26.0M |
MiniMed Group: income statement and cash flow
MiniMed Group, Q2 2026: revenue $843M (+17% year over year), operating margin 0.6%. The chart follows the revenue to costs, profit and cash.
MiniMed Group: every quarter, Q/Q and Y/Y → Open in the app
Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.